Bullish option flow detected in TG Therapeutics with 5,074 calls trading, 1.7x expected, and implied vol increasing over 3 points to 107.63%. Apr-24 16 calls and 3/1 weekly 14 calls are the most active options, with total volume in those strikes near 1,100 contracts. The Put/Call Ratio is 0.18. Earnings are expected on February 28th.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TGTX:
- TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)
- TG Therapeutics announces European launch of BRIUMVI
- TGTX Upcoming Earnings Report: What to Expect?
- TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update
- TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum